A carregar...
CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS
OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...
Na minha lista:
| Publicado no: | AACE Clin Case Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association of Clinical Endocrinologists
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/ https://ncbi.nlm.nih.gov/pubmed/32984529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|